Novel biomarker found in spinocerebellar ataxia 3

Takeaway

  • Serum neurofilament light protein (sNfL) levels were found to be correlated with disease severity in people with spinocerebellar ataxia type 3 (SCA3).

Why this matters

    In the future, sNfL levels may be used as a biomarker to determine pathological state and inform treatment options for patients with SCA3.